(+)-Matrine
CAS No. 519-02-8
(+)-Matrine( NSC 146051 | NSC 318810 )
Catalog No. M14816 CAS No. 519-02-8
Matrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 25MG | 34 | In Stock |
|
| 50MG | 49 | In Stock |
|
| 100MG | 69 | In Stock |
|
| 200MG | 111 | In Stock |
|
| 500MG | 245 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(+)-Matrine
-
NoteResearch use only, not for human use.
-
Brief DescriptionMatrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.
-
DescriptionMatrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.
-
In VitroCell Viability Assay Cell Line:A549, SMMC-7721 cells Concentration:0-500 μg/mL for A549 cells, 0-1.5 mg/mL for SMMC-7721 cellsIncubation Time:24-72 h Result:Inhibited the growth of A549 and SMMC-7721 cells.Western Blot AnalysisCell Line:A549, SMMC-7721 cells Concentration:100-250 μg/mL for A549 cells, 0.5-1 mg/mL for SMMC-7721 cellsIncubation Time:24 h Result:Down-regulated the expression of anti-apoptotic protein (Bcl-2) and up-regulated the level of pro-apoptotic protein (bax).ImmunofluorescenceCell Line:HK2 cells Concentration:10 μM Incubation Time:48 h Result:Increased SIRT3 expression reduced under cisplatin stimuli.
-
In VivoAnimal Model:Xenograft male C57BL/6mice model (LLC cells)Dosage:40 and 80 mg/kg for 16 consecutive days Administration:Intragastric administration Result:Inhibited tumors growth.Decreased the ratio of CD206+/F4/80+, promoted the expression of CD4+ and CD8+ T cells, and inhibited the expression of Th2 in tumor and spleen tissues. Animal Model:Cisplatin-induced acute kidney injury (AKI) mice model Dosage:5 mg/kg daily for 4 days Administration:Intraperitoneal injections Result:Attenuated tubular injury observed in AKI mice, including renal tubular necrosis,formation of tubular casts, cytoplasmic vacuoles and renal infiltrationof inflammatory cells in mice.Decreased serum levels of TNF-a and IL-6 and the phosphorylation of NF-κB, activated SIRT3/OPA1 axis and improved mitochondrial function.
-
SynonymsNSC 146051 | NSC 318810
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
Recptorκ-opioid receptor
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number519-02-8
-
Formula Weight248.37
-
Molecular FormulaC15H24N2O
-
Purity>98% (HPLC)
-
SolubilityEthanol: 49 mg/mL (197.29 mM); Water: 11 mg/mL warmed (44.29 mM); DMSO: 49 mg/mL (197.29 mM)
-
SMILESO=C1CCC[C@@H]2[C@H]3CCCN4CCC[C@H]([C@@H]34)CN12
-
Chemical Name(41S,7aS,13aR,13bR)-dodecahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
PL 017
Selective μ opioid receptor agonist (IC50 values are 5.5 and > 10000 nM for inhibition of 125I-FK 33,824 and 125I-DADLE binding to μ and δ sites respectively). Produces naloxone-reversible analgesia, catalepsy and hyperthermia following central administration in rats in vivo.
-
Calenduloside E
Calenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
-
SNC-80
A highly selective, non-peptide agonist of the δ-opioid receptor (δ-OR) with IC50/Ki of 2.73/0.18 nM; displays >2,000-fold selectivity over the μ-opioid receptor.
Cart
sales@molnova.com